Xolair (omalizumab) - Roche, Novartis
barzolvolimab (CDX-0159) - Celldex
https://eaaci2026.process.y-congress.com/ScientificProcess/schedule/?sessionGuid=95f2fabb-227e-4b3d-bb64-81d9880e4a51&setLng=en
 
M. Metz1; AM. Giménez-Arnau2; J. Peter3; E. Mitha4; J. Leflein5; M. Gotua6; B. Kwiek7; U. Chaudhry8; D. Alvarado9; D. Maurer9; L. Duan9; H. Lu9; S. Greenberg10; D. Young11; J. Bernstein12
 
Mar 23, 2026
 
Prev Next